AAAAAA
Results:
1-14
|
Results: 14
Authors:
RUMP LC
SCHWERTFEGER E
OBERHAUSER V
Citation: Lc. Rump et al., AT1 AND AT2 RECEPTORS ARE INVOLVED IN NORADRENALINE RELEASE IN HUMAN ATRIA, Hypertension, 32(4), 1998, pp. 206-206
Authors:
RUMP LC
OBERHAUSER V
SCHWERTFEGER E
SCHOLLMEYER P
Citation: Lc. Rump et al., EXPERIMENTAL-EVIDENCE TO SUPPORT ELITE, Lancet, 351(9103), 1998, pp. 644-645
Authors:
VONEND O
SCHWERTFEGER E
VONKUGELGEN I
RUMP LC
Citation: O. Vonend et al., ATP NORADRENALINE CORELEASE IN HUMAN KIDNEY - MODULATORY EFFECTS OF ALPHA(1)-ADRENOCEPTOR AND ALPHA(2)-ADRENOCEPTOR AGONISTS/, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 86-86
Authors:
SCHWERTFEGER E
VONEND O
VONKUGELGEN I
SCHOLLMEYER P
RUMP LC
Citation: E. Schwertfeger et al., RENAL NORADRENALINE ATP COTRANSMISSION IN HUMANS/, Journal of the American Society of Nephrology, 8, 1997, pp. 1885-1885
Authors:
RUMP LC
WEHRENS J
SCHWERTFEGER E
KRUMME B
SCHOLLMEYER P
Citation: Lc. Rump et al., EFFECT OF TACROLIMUS AND CYCLOSPORINE-A ON RAT RENAL VASCULAR TONE, Journal of the American Society of Nephrology, 8, 1997, pp. 3099-3099
Authors:
RUMP LC
BERLIT T
SCHWERTFEGER E
BEYERSDORF F
SCHOLLMEYER P
BOHMANN C
Citation: Lc. Rump et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION UNMASKS THE SYMPATHOFACILITATORY EFFECT OF BRADYKININ IN HUMAN RIGHT ATRIUM, Journal of hypertension, 15(11), 1997, pp. 1263-1270
Authors:
RUMP LC
RIESS M
SCHWERTFEGER E
MICHEL MC
BOHMANN C
SCHOLLMEYER P
Citation: Lc. Rump et al., PREJUNCTIONAL NEUROPEPTIDE-Y RECEPTORS IN HUMAN KIDNEY AND ATRIUM, Journal of cardiovascular pharmacology, 29(5), 1997, pp. 656-661
Authors:
BOHMANN C
SCHWERTFEGER E
VONKUGELGEN I
SCHOLLMEYER P
RUMP C
Citation: C. Bohmann et al., EXTRACELLULAR ATP IN THE HUMAN KIDNEY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2119-2119
Authors:
SCHWERTFEGER E
GROTZ W
KRAMERGUTH A
SCHOLLMEYER P
RUMP LC
Citation: E. Schwertfeger et al., A PROSPECTIVE CONTROLLED 1-YEAR STUDY OF SANDIMMUNE NEORAL IN RENAL-TRANSPLANTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3381-3381
Authors:
SCHWERTFEGER E
KELLER E
GROTZ W
SCHOLLMEYER P
RUMP LC
Citation: E. Schwertfeger et al., PHARMACOKINETIC PROFILE OF CYCLOSPORINE-A AFTER CONVERSION TO SANDIMMUN OPTORAL - INFLUENCE ON AMBULATORY BLOOD-PRESSURE IN RENAL-TRANSPLANT PATIENTS, Clinical nephrology, 45(5), 1996, pp. 349-351
Authors:
RUMP LC
BOHMANN C
SCHWERTFEGER E
KRUMME B
VONKUGELGEN I
SCHOLLMEYER P
Citation: Lc. Rump et al., EXTRACELLULAR ATP IN THE HUMAN KIDNEY - MODE OF RELEASE AND VASCULAR EFFECTS, Journal of autonomic pharmacology, 16(6), 1996, pp. 371-375
Authors:
KRUMME B
BLUM U
SCHWERTFEGER E
FLUGEL P
HOLLSTIN F
SCHOLLMEYER P
RUMP LC
Citation: B. Krumme et al., DIAGNOSIS OF RENOVASCULAR DISEASE BY INTRARENAL AND EXTRARENAL DOPPLER SCANNING, Kidney international, 50(4), 1996, pp. 1288-1292
Authors:
RUMP LC
RIERAKNORRENSCHILD G
SCHWERTFEGER E
BOHMANN C
SPILLNER G
SCHOLLMEYER P
Citation: Lc. Rump et al., DOPAMINERGIC AND ALPHA-ADRENERGIC CONTROL OF NEUROTRANSMISSION IN HUMAN RIGHT ATRIUM, Journal of cardiovascular pharmacology, 26(3), 1995, pp. 462-470
Authors:
RUMP LC
SCHWERTFEGER E
SCHAIBLE U
FRAEDRICH G
SCHOLLMEYER P
Citation: Lc. Rump et al., BETA(2)-ADRENERGIC RECEPTOR AND ANGIOTENSIN-II RECEPTOR MODULATION OFSYMPATHETIC NEUROTRANSMISSION IN HUMAN ATRIA, Circulation research, 74(3), 1994, pp. 434-440
Risultati:
1-14
|